Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H10N2.H2O4S |
| Molecular Weight | 220.246 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(O)(=O)=O.CC1=CC(N)=CC=C1N
InChI
InChIKey=KZTWOUOZKZQDMN-UHFFFAOYSA-N
InChI=1S/C7H10N2.H2O4S/c1-5-4-6(8)2-3-7(5)9;1-5(2,3)4/h2-4H,8-9H2,1H3;(H2,1,2,3,4)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Is benzoquinone the prohapten in cross-sensitivity among aminobenzene compounds? | 1998 Dec |
|
| Hair dye-sensitized hairdressers: the cross-reaction pattern with new generation hair dyes. | 2002 Jun |
|
| Contact allergy to ingredients of hair cosmetics in female hairdressers and clients--an 8-year analysis of IVDK data. | 2003 Nov |
|
| Hair dye contact allergy: quantitative exposure assessment of selected products and clinical cases. | 2004 Jun |
|
| Different results of the Salmonella umu test between three isomers of phenylenediamine (PDA) derivatives. | 2006 |
|
| Toluene-2,5-diamine may be an isolated allergy in individuals sensitized by permanent hair dye. | 2007 Sep |
|
| Severe inflammatory and keloidal, allergic reaction due to para-phenylenediamine in temporary tattoos. | 2010 Mar-Apr |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Code | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2179
Created by
admin on Fri Dec 15 19:43:03 UTC 2023 , Edited by admin on Fri Dec 15 19:43:03 UTC 2023
|
PRIMARY | |||
|
615-50-9
Created by
admin on Fri Dec 15 19:43:03 UTC 2023 , Edited by admin on Fri Dec 15 19:43:03 UTC 2023
|
PRIMARY | |||
|
22856
Created by
admin on Fri Dec 15 19:43:03 UTC 2023 , Edited by admin on Fri Dec 15 19:43:03 UTC 2023
|
PRIMARY | |||
|
8PSD05SPE2
Created by
admin on Fri Dec 15 19:43:03 UTC 2023 , Edited by admin on Fri Dec 15 19:43:03 UTC 2023
|
PRIMARY | |||
|
6369-59-1
Created by
admin on Fri Dec 15 19:43:03 UTC 2023 , Edited by admin on Fri Dec 15 19:43:03 UTC 2023
|
ALTERNATIVE | |||
|
DTXSID50872532
Created by
admin on Fri Dec 15 19:43:03 UTC 2023 , Edited by admin on Fri Dec 15 19:43:03 UTC 2023
|
PRIMARY | |||
|
1482534
Created by
admin on Fri Dec 15 19:43:03 UTC 2023 , Edited by admin on Fri Dec 15 19:43:03 UTC 2023
|
PRIMARY | RxNorm | ||
|
1703
Created by
admin on Fri Dec 15 19:43:03 UTC 2023 , Edited by admin on Fri Dec 15 19:43:03 UTC 2023
|
PRIMARY | |||
|
8PSD05SPE2
Created by
admin on Fri Dec 15 19:43:03 UTC 2023 , Edited by admin on Fri Dec 15 19:43:03 UTC 2023
|
PRIMARY | |||
|
228-871-4
Created by
admin on Fri Dec 15 19:43:03 UTC 2023 , Edited by admin on Fri Dec 15 19:43:03 UTC 2023
|
ALTERNATIVE | |||
|
210-431-8
Created by
admin on Fri Dec 15 19:43:03 UTC 2023 , Edited by admin on Fri Dec 15 19:43:03 UTC 2023
|
PRIMARY | |||
|
C007303
Created by
admin on Fri Dec 15 19:43:03 UTC 2023 , Edited by admin on Fri Dec 15 19:43:03 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
